Skip to main content
. 2018 Apr 23;17(6):8316–8324. doi: 10.3892/mmr.2018.8919

Figure 1.

Figure 1.

Liraglutide treatment ameliorates metabolic disorders in ZDF rats. (A) Body weight and (B) fasting blood glucose were evaluated in ZL rats and ZDF rats with or without liraglutide treatment. Serum levels of (C) ALT and (D) AST were determined in ZL rats and ZDF rats with or without liraglutide treatment. Serum (E) LDL-c and (F) TC levels were examined in ZL rats and ZDF rats with or without liraglutide treatment. Data are presented as the mean ± standard error (n=5 rats for each group). *P<0.05, **P<0.01 and ***P<0.001 vs. ZL; #P<0.05 and ##P<0.01 vs. ZDF+Saline. ZDF, Zucker diabetic fatty; ZL, Zucker lean; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDL-c, low density lipoprotein cholesterol; TC, total cholesterol.